Jupiter Neurosciences, Inc. (JUNS)
3.06
-0.03
(-0.97%)
USD |
NASDAQ |
Sep 10, 16:00
3.08
+0.02
(+0.65%)
After-Hours: 20:00
Jupiter Neurosciences Total Liabilities (Quarterly) : 4.085M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.085M |
| March 31, 2026 | 6.732M |
| December 31, 2025 | 7.396M |
| September 30, 2025 | 2.519M |
| June 30, 2025 | 2.628M |
| March 31, 2025 | 1.898M |
| December 31, 2024 | 2.030M |
| September 30, 2024 | 5.836M |
| June 30, 2024 | 5.492M |
| March 31, 2024 | 6.137M |
| Date | Value |
|---|---|
| December 31, 2023 | 5.950M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 7.38M |
| September 30, 2022 | 6.406M |
| June 30, 2022 | 7.006M |
| March 31, 2022 | 6.223M |
| December 31, 2021 | 5.845M |
| September 30, 2021 | 5.551M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Jaguar Health, Inc. | 29.27M |
| Atai Beckley, Inc. | 88.36M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.719M |
| Shareholders Equity (Quarterly) | -0.366M |
| Debt to Equity Ratio | -4.852 |
| Current Ratio | 0.657 |
| Net Debt Paydown Yield | -2.94% |